173 related articles for article (PubMed ID: 7048336)
1. Bromocriptine and glucose tolerance in acromegalics.
Dolecek R; Kubis M; Sajnar J; Závada M
Pharmatherapeutica; 1982; 3(2):100-6. PubMed ID: 7048336
[TBL] [Abstract][Full Text] [Related]
2. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
[TBL] [Abstract][Full Text] [Related]
3. Chronic bromocriptine treatment and glucose intolerance in acromegaly.
Popović V; Micić D; Nesović M; Djordjević P; Mićić J; Djurić DS
Exp Clin Endocrinol; 1985 Jun; 85(3):351-7. PubMed ID: 3899685
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of suppression of growth hormone levels following a 75g oral glucose tolerance test.
Nazaimoon WM; Ng ML; Satgunasingam N; Khalid BA
Med J Malaysia; 1992 Jun; 47(2):103-9. PubMed ID: 1494329
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine levels in acromegaly patients.
Hekimsoy Z; Ozmen B; Ulusoy S
Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
[TBL] [Abstract][Full Text] [Related]
6. Bromocriptine reduces growth hormone in acromegaly.
Bell PM; Atkinson AB; Hadden DR; Kennedy L; Leslie H; Merrett JD; Sheridan B
Arch Intern Med; 1986 Jun; 146(6):1145-9. PubMed ID: 3718102
[TBL] [Abstract][Full Text] [Related]
7. Glucose tolerance and plasma immunoreactive insulin levels in acromegalics before and after selective transsphenoidal surgery.
Roelfsema F; Frölich M
Clin Endocrinol (Oxf); 1985 Apr; 22(4):531-7. PubMed ID: 3886210
[TBL] [Abstract][Full Text] [Related]
8. The effect of bromocriptine on insulin secretion and glucose tolerance in patients with acromegaly.
Feek CM; Bevan JS; Taylor S; Brown NS; Baird JD
Clin Endocrinol (Oxf); 1981 Nov; 15(5):473-8. PubMed ID: 7035013
[TBL] [Abstract][Full Text] [Related]
9. Effect of CB-154 therapy on the glucose tolerance, IRI and GH response to glucose administration in acromegaly.
Demura R; Yamaguchi H; Demura H; Shizume K
Endocrinol Jpn; 1978 Aug; 25(4):355-9. PubMed ID: 710371
[TBL] [Abstract][Full Text] [Related]
10. The influence of thyroid function on the diabetogenic action of triamcinolone in man. Glucose, insulin and growth hormone patterns after on oral glucose load.
Zamrazil V; Nedvĭdková J; Felt V; Nĕmec J; Havelka J
Horm Metab Res; 1976 Jul; 8(4):282-6. PubMed ID: 955557
[TBL] [Abstract][Full Text] [Related]
11. True insulin and intact proinsulin levels in acromegalic patients.
Tavares EF; Dalbosco IS; Abucham J; Russo EM
Eur J Endocrinol; 1996 May; 134(5):549-53. PubMed ID: 8664973
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine acute effect on insulin, glucagon and growth hormone levels in acromegalic patients.
Fedele D; Molinari M; Meneghel A; Valerio A; Muggeo M; Tiengo A
J Endocrinol Invest; 1980; 3(2):149-53. PubMed ID: 6993548
[TBL] [Abstract][Full Text] [Related]
13. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone and insulin-like growth factor binding protein-1 responses to oral glucose in patients with primary hyperparathyroidism.
Díez JJ; Grande C; Méndez J; González-Gancedo P; Iglesias P
Clin Endocrinol (Oxf); 2006 Jul; 65(1):27-34. PubMed ID: 16817815
[TBL] [Abstract][Full Text] [Related]
15. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
16. [Some alternatives of bromocriptin action of glucose tolerance in acromegalics (author's transl)].
Dolecek R; Závada M
Cas Lek Cesk; 1981; 120(51):1568-72. PubMed ID: 7034947
[No Abstract] [Full Text] [Related]
17. [Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine].
Carmina E; Lanzara P; Lo Coco R; Longo RA; Jannì A
Arch Sci Med (Torino); 1979; 136(3):421-5. PubMed ID: 549547
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of acromegaly using bromocriptine].
Köbberling J; Schwinn G; Dirks H
Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
[TBL] [Abstract][Full Text] [Related]
19. Serum growth hormone, insulin and blood sugar responses to oral glucose in protein energy malnutrition.
Garg SK; Marwaha RK; Ganpathy V; Sialy R; Thapa BR; Walia BN; Dash RJ
Trop Geogr Med; 1989 Jan; 41(1):9-13. PubMed ID: 2503912
[TBL] [Abstract][Full Text] [Related]
20. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
